Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Small Business Times.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on May 7, 2025
WANG & LEE GROUP, Inc. Bid Price Deficiency
GlobeNewswire
·
May 7, 2025
HONG KONG, May 07, 2025 (GLOBE NEWSWIRE) -- WANG …
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 7, 2025
CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …
Fortinet Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Highlights Total revenue of $1.54 billion, up 14% year over year Product revenue of $459 million, up 12% year over year Billings of $1.60 billion, up 14% year over year1 Unified SASE ARR2 up 26% and Security Operations ARR2 up 30%, year over year Record …
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
GlobeNewswire
·
May 7, 2025
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …
Robinhood Markets, Inc. to Present at the J.P. Morgan Global Technology, Media and Communications Conference on May 14, 2025
GlobeNewswire
·
May 7, 2025
MENLO PARK, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming J.P. Morgan Global Technology, Media and Communications Conference on Wednesday, May 14, …
Open Lending Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
AUSTIN, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions for financial institutions, today reported financial …
Noodles & Company Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
BROOMFIELD, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- Noodles …
RxSight, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
ALISO VIEJO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for …
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid …
BBSI Reports Strong First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
- Revenues up 10% to $292.6 Million with Gross Billings up 9% to $2.09 Billion - VANCOUVER, Wash., May 07, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (“BBSI” or the “Company”) (NASDAQ: BBSI), a leading provider of business management …
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
GlobeNewswire
·
May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …
H&R Block Reports Fiscal 2025 Third Quarter Results
GlobeNewswire
·
May 7, 2025
— Delivered Revenue Growth of 4%, Net Income Growth of 5%, and EPS Growth of 9% — — Improved Volume and Market Share Trends in Assisted Channel Through April 30 — — Reaffirms Full Year 2025 Outlook — KANSAS CITY, Mo., May 07, 2025 (GLOBE NEWSWIRE) -- H…
Encore Capital Group Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Favorable purchasing conditions continue in U.S. market Global portfolio purchases up 24% to $368 million, including record $316 million in U.S. Global collections up 18% to $605 million, including record $454 million in U.S. Earnings per share of $1.93 …
Century Aluminum Company Reports First Quarter 2025 Results
GlobeNewswire
·
May 7, 2025
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data) Q1 2025 Q4 2024 Aluminum shipments ( …
RCM Technologies, Inc. Announces First Quarter Results
GlobeNewswire
·
May 7, 2025
PENNSAUKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health …
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …
Clarisil Pro Under Review: Proven Hearing Loss Support Supplement with Secret Navajo Remedy
GlobeNewswire
·
May 7, 2025
New York, May 07, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why hearing loss is on the rise—and how environmental and lifestyle factors play a major role The most common causes of auditory decline, including inflammation, nutritional …
SLR Investment Corp. Announces Quarter Ended March 31, 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Net Investment Income of $0.41 Per Share for Q1 2025; Declared Quarterly Distribution of $0.41 Per Share; Stable NAV/Strong Credit Quality NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company”, “SLRC”, “we”, “us”, or …
Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress
GlobeNewswire
·
May 7, 2025
Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …
LegalZoom Reports Strong First Quarter 2025 Financial Results, Reiterates 2025 Guidance of 5% Revenue Growth and Commitment to Profitability Targets
GlobeNewswire
·
May 7, 2025
Solid execution with first quarter results exceeding high end of outlook range First quarter revenue of $183.1 million, up 5% year-over-year Subscription revenue of $116.3 million, an increase of 8% year-over-year, reflecting ongoing progress in …